A better environment for the UK life sciences’ sector is vital for the country’s economic recovery, the safeguarding of jobs and the future health of the nation.
The "ABPI manifesto for life sciences: Prescription for innovation", was launched with the support of the CBI, Imperial College and patients’ organisation National Voices. It explains that rapid improvements in the research and development environment are required to remain competitive in attracting and retaining investment in the UK and the top-level jobs that go with it.
Among the manifesto’s key calls for action are:
Delivering better patient health by creating incentives for clinical trials and better patient access to medicines through improved NICE processes
Driving the industry’s contribution to the UK economy by reviewing the tax system and introducing new tax regimes to support the generation, retention and exploitation of intellectual property in the UK
Giving real power to the body in charge of ensuring the uptake of innovative medicines so that patients actually receive them
Changing the official definition of the value of medicines to make it align with the view of the public, patients and healthcare professionals
For more detailed information please download the ABPI manifesto for life sciences: Prescription for innovation (PDF, 489KB)